Prof Matthew Simunovic

About

Matthew Simunovic is an ophthalmic surgeon with subspecialty training in the surgical and medical management of disorders of the retina and vitreous. He is a Fellow of the Royal Australian and New Zealand College of Ophthalmologists (FRANZCO), a vitreoretinal surgeon at Sydney Eye Hospital and the Sydney Children’s Hospitals Network, and a Professor of Ophthalmology & Visual Science at the University of Sydney.

Matthew attended medical school at the University of Cambridge (MB BCHIR with distinction in medicine & surgery), where he also gained his PHD (for a thesis entitled The Cone Dystrophies). He completed specialist ophthalmic surgical training at Sydney Eye Hospital and undertook subspecialty fellowship training in vitreoretinal surgery at the University of British Columbia, Vancouver, and in medical retina at Moorfields Eye Hospital, London. He subsequently completed a combined clinical and clinical research fellowship in vitreoretinal surgery at the John Radcliffe Hospital/Nuffield Laboratory of Ophthalmology, University of Oxford.

Matthew’s clinical practice focuses on vitreoretinal surgery (including small gauge vitrectomy, scleral buckling and macular surgery), medical retinal disorders, and complex cataract surgery in which vitreoretinal intervention may be required (including sutured and sutureless scleral fixation techniques for intraocular lenses). He was the first surgeon in the Southern Hemisphere to perform surgery to deliver approved retinal gene therapy (Luxturna).

Prof. Simunovic is actively engaged in research as the leader of the Retinal Disease and Rescue Group at the University of Sydney and in clinical teaching at the University of Sydney and Sydney Eye Hospital, where he is the director of the Vitreoretinal Fellowship Program. Additionally, he is a member of the Board of Directors of the Sydney Eye Hospital Foundation and the Ophthalmic Research Institute of Australia. He sits on the Research Standing Committee of the Asia-Pacific Academy of Ophthalmology. In 2018, he was appointed to the Macula Society, USA.